UnitedHealth Suggests Gilead's Harvoni as Preferred Hepatitis C Treatment

by Vishnuprasad on  January 29, 2015 at 7:27 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

UnitedHealth Group Inc, the largest U.S. health insurer, has mentioned Gilead Sciences Inc's Harvoni as the preferred hepatitis C treatment on its 2015 commercial drug coverage list.
UnitedHealth Suggests Gilead's Harvoni as Preferred Hepatitis C Treatment
UnitedHealth Suggests Gilead's Harvoni as Preferred Hepatitis C Treatment

According to sources, Gilead and AbbVie have been battling for hepatitis C market share since the approval in December for an AbbVie drug that challenges Gilead's blockbusters.

Insurers and third party administrators have been striking deals for preferred or exclusive status in exchange for discounts for 2015.

UnitedHealth's drug coverage list, which will be effective from February 1, applies to all of the company's commercial, fully insured customers who use its Optum RX pharmacy benefit manager and self-insured customers.

The update to the formulary which is available on the company's website also applies to its Medicaid, Medicare and military contracts.

UnitedHealth spokesman Tyler Mason said that, "We are constantly working to deliver value and manage costs for customers and consumers throughout our business."



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Hepatitis A Hepatitis B Vasculitis Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Hepatitis Needlestick Injuries Top Foods to Beat Chronic Fatigue Syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive